<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01946828</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-13-AM-0280-CTIL</org_study_id>
    <nct_id>NCT01946828</nct_id>
  </id_info>
  <brief_title>Evaluation of the FIM - a Non Invasive Device for Temporarily and Quick Pupil Dilation (Mydriasis)</brief_title>
  <acronym>TP 7601-CL</acronym>
  <official_title>Evaluation of the FIM - a Non Invasive Device for Temporarily and Quick Pupil Dilation (Mydriasis)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical trial is to evaluate the FIM optimal configuration and confirm
      the safety and performance/efficacy of the FIM when exposed to a larger and more varied
      population of users.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      70 Eligible subjects will be enrolled to the study and examined with the FIM to determine the
      degree of pupil dilation/Contraction resistance.

      The study will be conducted in two main stages: 1) pupil dilation measuring and 2) functional
      examination. The tests' sequence will be randomized, at least 30 minutes between each test.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>4 months</time_frame>
    <description>number, severity and causality of unexpected, device related adverse events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functionality</measure>
    <time_frame>4 months</time_frame>
    <description>Functionality - ability to perform standard ophthalmologic examination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Usability</measure>
    <time_frame>4 months</time_frame>
    <description>Device usability and user satisfaction</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Pupil Dilation</condition>
  <arm_group>
    <arm_group_label>FIM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>safety and efficacy of the FIM when exposed to a large and varied population of patients and users and operated according to its instructions for use</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FIM</intervention_name>
    <description>Field Induced Mydriasis device</description>
    <arm_group_label>FIM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy and not diagnosed with any chronic disease that might influence the eye and
             pupilary muscle.

          -  Age 18-45 years old.

          -  Willing and able to sign the informed consent, after reading the study information
             form

        Exclusion Criteria:

          -  Any known or diagnosed neurological disorders.

          -  A known medical history of ophthalmic surgery or any other disease that might
             influence the iris control muscle.

          -  Volunteers with a narrow or closed angle of the anterior chamber

          -  Presence of a corneal pathology which precludes measurement of the pupil dilatation

          -  Using of psychiatric medications

          -  Pregnancy

          -  Recent use (last 48hr) of pupil dilator eye drops.

          -  The volunteer is participating in other trials using drugs or devices

          -  Drug or alcohol abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Keren El Ogalbo</last_name>
    <phone>972-36974165</phone>
    <email>kerenel@tlvmc.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adi Gluzberg</last_name>
    <phone>+972-52-6401020</phone>
    <email>adi_g@medicsense.om</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tel-Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Keren Elia Ogalbo</last_name>
      <phone>+972-36974165</phone>
      <email>kerenel@tlvmc.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Adi Gluzberg</last_name>
      <phone>+97252-6401020</phone>
      <email>adi_g@medicsense.com</email>
    </contact_backup>
    <investigator>
      <last_name>Adi Michaeli, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Moshe Lazar, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.ati-amt.com</url>
    <description>ATI Advanced Medical Technologies</description>
  </link>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2013</study_first_submitted>
  <study_first_submitted_qc>September 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2013</study_first_posted>
  <last_update_submitted>September 16, 2013</last_update_submitted>
  <last_update_submitted_qc>September 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Field Induced Mydriasis</keyword>
  <keyword>FIM</keyword>
  <keyword>ATI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
    <mesh_term>Mydriasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

